Orr Inbar

Sales & Marketing

In order to discuss the current unsettled landscape, and just how tariffs might affect patients, pharmaphorum spoke with Orr Inbar of QuantHealth.

Digital

Over 90% of experimental therapies that reach human trials fail to make it to market.

Patients

Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.